Cryptogenic stroke and high-risk patent foramen ovale: the DEFENSE-PFO trial
Background : Recent reports showing the favorable role of patent foramen ovale (PFO) closure
in patients with cryptogenic stroke have raised the issue of selecting optimal candidates. …
in patients with cryptogenic stroke have raised the issue of selecting optimal candidates. …
Randomized trial evaluating percutaneous coronary intervention for the treatment of chronic total occlusion: the DECISION-CTO trial
Background: Procedural results for percutaneous coronary intervention (PCI) in coronary
vessels with chronic total occlusion (CTO) have improved in recent years, and PCI strategies …
vessels with chronic total occlusion (CTO) have improved in recent years, and PCI strategies …
Randomized trial of stents versus bypass surgery for left main coronary artery disease: 5-year outcomes of the PRECOMBAT study
…, PH Lee, M Chang, HW Park, SW Lee, CW Lee… - Journal of the American …, 2015 - jacc.org
Background : In a previous randomized trial, we found that percutaneous coronary intervention
(PCI) was not inferior to coronary artery bypass grafting (CABG) for the treatment of …
(PCI) was not inferior to coronary artery bypass grafting (CABG) for the treatment of …
Heterogeneity of treatment effects in an analysis of pooled individual patient data from randomized trials of device closure of patent foramen ovale after stroke
Importance Patent foramen ovale (PFO)–associated strokes comprise approximately 10% of
ischemic strokes in adults aged 18 to 60 years. While device closure decreases stroke …
ischemic strokes in adults aged 18 to 60 years. While device closure decreases stroke …
Ten-year outcomes after drug-eluting stents versus coronary artery bypass grafting for left main coronary disease: extended follow-up of the PRECOMBAT trial
DW Park, JM Ahn, H Park, SC Yun, DY Kang, PH Lee… - Circulation, 2020 - Am Heart Assoc
Background: Long-term comparative outcomes after percutaneous coronary intervention (PCI)
with drug-eluting stents and coronary-artery bypass grafting (CABG) for left main coronary …
with drug-eluting stents and coronary-artery bypass grafting (CABG) for left main coronary …
Successful recanalization of native coronary chronic total occlusion is not associated with improved long-term survival
PH Lee, SW Lee, HS Park, SH Kang, BJ Bae… - JACC: Cardiovascular …, 2016 - jacc.org
Objectives : The purpose of this study was to evaluate long-term clinical outcomes after drug-eluting
stent–supported percutaneous coronary intervention (PCI) for native coronary total …
stent–supported percutaneous coronary intervention (PCI) for native coronary total …
Left main coronary artery disease: secular trends in patient characteristics, treatments, and outcomes
Left main coronary artery (LMCA) disease is the highest-risk lesion subset of ischemic heart
disease, and has traditionally been an indication for coronary artery bypass grafting (CABG). …
disease, and has traditionally been an indication for coronary artery bypass grafting (CABG). …
Fractional flow reserve and cardiac events in coronary artery disease: data from a prospective IRIS-FFR registry (Interventional Cardiology Research Incooperation …
…, TJ Hong, SY Lee, M Han, PH Lee, SJ Kang, SW Lee… - Circulation, 2017 - Am Heart Assoc
Background: We evaluated the prognosis of deferred and revascularized coronary stenoses
after fractional flow reserve (FFR) measurement to assess its revascularization threshold in …
after fractional flow reserve (FFR) measurement to assess its revascularization threshold in …
Comorbidities frequency in Takotsubo syndrome: an international collaborative systematic review including 1109 patients
…, O Lairez, M Larrauri-Reyes, PH Lee… - The American journal of …, 2015 - Elsevier
Background To identify predisposing factors that can result in the onset of takotsubo
syndrome, we performed an international, collaborative systematic review focusing on clinical …
syndrome, we performed an international, collaborative systematic review focusing on clinical …
Clinically significant bleeding with ticagrelor versus clopidogrel in Korean patients with acute coronary syndromes intended for invasive management: a randomized …
…, PH Lee, SW Lee, SW Park, SW Choi, SG Lee… - Circulation, 2019 - Am Heart Assoc
Background: Owing to the differential propensity for bleeding and ischemic events with
response to antiplatelet therapy, the safety and effectiveness of potent P2Y12 inhibitor ticagrelor …
response to antiplatelet therapy, the safety and effectiveness of potent P2Y12 inhibitor ticagrelor …